- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07379359
The ADHD Kids´ Study for Children 9-12 Years of Age (OutSmarters)
January 26, 2026 updated by: Dagmar Kristín Hannesdóttir, University of Iceland
The ADHD Kids´ Study: Randomized Clinical Trial on the OutSMARTers Program and Individual Counseling for Children Aged 9-12 With ADHD
The aim of the study is to compare the efficacy of The OutSMARTers program- an ADHD skills training group program for children aged 9-12 to customized individual counseling provided by a professional, The Kid Counseling Program.
Approximately 100 children will be randomly assigned to either intervention or a small wait-list group who will after a five-week-waiting period receive either intervention.
Following the intervention, parents, children, and teachers will evaluate the effects on communication skills, well-being, and emotional regulation.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
Attention-deficit hyperactivity disorder (ADHD) is an impairing neurodevelopmental disorder among children and adolescents that makes it difficult to cope with challenges of everyday life.
Although various interventions have been developed to support parents of children with ADHD, few have been specifically designed for the children themselves, particularly interventions that focus directly on emotion regulation, problem-solving, communication and emotional well-being.
The study is a randomized controlled trial (RCT) comparing the effectiveness of the OutSMARTers program, a skills-training group program based on cognitive- behavioral therapy (CBT) elements for children with ADHD.
The program includes training in emotional regulation, social skills, self-control and problem-solving within a behavior modification framework.
The comparison intervention, The Kid Counseling Program, consists of five sessions of individual counseling with similar content as in the OutSMARTers program, provided by a professional.
The participants of this study will be approximately 100 children aged 9-12 that have been diagnosed with ADHD.
Various methods will be used to assess outcomes, drawing on data from multiple sources through repeated measurements, including reports from parents, teachers, and the children themselves.
The scientific goal of the study is to evaluate the efficacy of the OutSMARTers program, a group- based intervention delivered in 10 sessions over the course of 5 weeks, compared to brief individual counseling provided by a professional but not in a group of same-age peers.
Positive changes in emotional regulation, communication skills, and well-being are expected in both groups.
However, it is also possible that certain subgroups (e.g.
children with or without comorbidities such as anxiety) may benefit more from one intervention over the other.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dagmar Kr Hannesdottir, PhD
- Phone Number: +354 525 4351
- Email: dkh@hi.is
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age: 9-12
- have an ADHD diagnosis confirmed by a school psychologist
- children need to be fluent in Icelandic
- Parents need to be fluent in Icelandic or English
Exclusion Criteria:
- Children need to have an IQ of 70 or higher (WISC-IV test or WPSSI-R test)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The OutSMARTers program
Child directed group skills training and cognitive-behavior therapy
|
An intervention specifically designed to improve common difficulties that children with ADHD wrestle with daily.
The program consists of ten sessions (90 minutes each) conducted by two or three trainers working with a group of six children over the course of five weeks.
The children attend four different stations during the intervention: the Emotion station and the Friendship station in sessions one through five, and the Stopping station and the Solution station in the remaining five.
The program is fully manualized and was published in Icelandic in 2017 (Hannesdottir et al., 2017b).
A small RCT pilot study of the OutSMARTers program delivered in a clinical setting showed beneficial effects on emotion regulation skills, social skills and a reduction in ADHD symptoms as rated by parents (Hannesdottir et al., 2017a).
|
|
Experimental: The Kid Counseling Program
Child directed individual sessions, skills training and cognitive-behavior therapy.
|
The Kid Counseling Program consists of five 50-minute individual counseling sessions, each delivered by a professional, and based on the book Learning to Slow Down and Pay Attention (Nadeau & Dixon, 2004).
The content closely mirrors that of the OutSMARTers program and shares the same goal; to improve common deficits that children with ADHD face.
The key difference is that, unlike the OutSMARTers program, this intervention is individualized and does not include peer-based practice of the skills learned.
|
|
No Intervention: Wait-list control group
The Wait-list control group is assessed at pre and post (five week interval) and then receives either the OutSMARTers program or the Kid Counseling Program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Strengths and difficulties questionnaire (SDQ)
Time Frame: Baseline, upon completion of 5 week program, at the 6 month follow-up
|
SDQ assess behavior and well-being in children generally based on the following factors: emotional problems, behavioral problems, hyperactivity, social difficulties, and social competence.
Each item is scored on a 0-2-point Likert scale, where higher scores indicate more difficulties, except on the social competence factor.
Higher scores on the social competence factor indicate better social competence.
|
Baseline, upon completion of 5 week program, at the 6 month follow-up
|
|
Emotion Regulation Checklist (ERC)
Time Frame: Baseline, upon completion of 5 week program, 6 month follow-up
|
The ERC measures emotion regulation among youth.
Parents and teachers complete this questionnaire regarding the child's emotional regulation and negative mood.
The scale consists of 24 questions and has been validated in the general Icelandic population.
Each item is scored on a 1-4 Likert Scale.
Higher scores on the Lability/Negativity factor indicate more dysregulation and difficulties.
while higher scores on the Emotion Regulation factor indicate better emotion regulation skills.
|
Baseline, upon completion of 5 week program, 6 month follow-up
|
|
ADHD Rating Scale (ADHD)
Time Frame: Baseline, upon completion of 5 week program, 6 month follow-up
|
The ADHD scale assesses symptoms and impairment of attention-deficit/hyperactivity disorder, i.e. difficulties with concentration and hyperactive behavior.
These symptoms align with the diagnostic criteria of the DSM classification system.
Each item is scored on a 0-3 Likert Scale where higher scores indicate more ADHD symptoms.
Responses from parents and teachers are compared to the norms of Icelandic children.
|
Baseline, upon completion of 5 week program, 6 month follow-up
|
|
Revised Children's Anxiety and Depression Scale (RCADS)
Time Frame: Baseline, upon completion of 5 week program, 6 month follow-up
|
The RCADS is a commonly used questionnaire to screen for anxiety and depressive disorders and to assess changes following an intervention.
The RCADS is a 47-item questionnaire designed for parents and children (ages 8-17) and includes the following scales: Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Obsessive-Compulsive Disorder, and Depressive Symptoms.
Items are rated on a four-point scale: 0 = never, 1 = sometimes, 2 = often, 3 = always.
Higher scores indicate more anxiety and depressive symptoms.
The Icelandic version has acceptable psychometric properties in both general and clinical populations.
|
Baseline, upon completion of 5 week program, 6 month follow-up
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents-Revised Version (KINDL-R)
Time Frame: Baseline, upon completion of 5 week program, 6 month follow-up
|
Parents and children are asked to evaluate how well the child has been doing and feeling recently in terms of physical health, emotional well-being, self-esteem, family relationships, peer relationships, and school (Ravens-Sieberer & Bullinger, 1998 - see www.kindl.org).
Each item is scores on a Likert scale of 1-5 and higher scores indicate better quality of life for each factor.
|
Baseline, upon completion of 5 week program, 6 month follow-up
|
|
Social Skills Rating System (SSRS)
Time Frame: Baseline, upon completion of 5 week program, 6 month follow-up
|
Children complete an assessment on their social skills.
The questionnaire assesses Cooperation, Assertion, Self-control and Responsibility.
Items are scored on a 0-2 Likert scale where higher scores on each factor indicates better skills.
|
Baseline, upon completion of 5 week program, 6 month follow-up
|
|
Treatment satisfaction
Time Frame: Upon completion of 5 week program
|
Parents and children complete questions on treatment satisfaction.
The questions include some open comments, but most items are scored on a scale of 1-4, with higher ratings indicating more satisfaction.
|
Upon completion of 5 week program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 2, 2026
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2029
Study Registration Dates
First Submitted
September 27, 2025
First Submitted That Met QC Criteria
January 26, 2026
First Posted (Actual)
January 30, 2026
Study Record Updates
Last Update Posted (Actual)
January 30, 2026
Last Update Submitted That Met QC Criteria
January 26, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UI-2025-OutSMARTersADHDstudy
- 94059 (Other Grant/Funding Number: University of Iceland Research Fund)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
As the study includes repeated measures of a clinical child population, parts of the data will be classified as sensitive personal data and thus restricted by the permit from the National Bioethics Committee of Iceland.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention-Deficit/Hyperactivity Disorder (ADHD)
-
Çağlar Charles Daniel JaicksCompletedADHD | Attention Deficit Hyperactivity Disorder (ADHD)Turkey (Türkiye)
-
EMOTIVCompletedADHD | ADHD - Combined Type | ADHD - Attention Deficit Disorder With HyperactivitySouth Korea
-
Seattle Children's HospitalRecruitingADHD | ADHD - Attention Deficit Disorder With HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
I-Ching ChouBened Biomedical Co., Ltd.Enrolling by invitationADD/ADHD | ADHD - Attention Deficit Disorder With HyperactivityTaiwan
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Otsuka Pharmaceutical Co., Ltd.RecruitingAttention-Deficit Hyperactivity Disorder(ADHD)Japan
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on The OutSMARTers Program
-
Indiana UniversityIndiana University School of MedicineCompletedInsomnia | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
Suez Canal UniversityCompletedEndotracheal TubeEgypt
-
Mercedes García de QuesadaCívitas-UGR Chair: Sustainability, Innovation and Development, Granada, SpainCompletedCompassion | Anxiety | Psychological Distress | Attention | Empathy | Creativity | Life Stress | Emotional IntelligenceSpain
-
Mercedes García de QuesadaCívitas-UGR Chair: Sustainability, Innovation and Development, Granada, Spain and other collaboratorsCompletedCompassion | Anxiety | Psychological Distress | Attention | Empathy | Creativity | Life Stress | Emotional IntelligenceSpain
-
Foundation for Science, Health and Education, SpainHospital del Mar Research Institute (IMIM); La Caixa FoundationActive, not recruitingHealth Behavior | Healthy Lifestyle | Heart Disease Risk FactorsSpain
-
Cairo UniversityRecruiting
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Major Depression | Chronic Mental DisorderUnited States
-
Istanbul Medipol University HospitalCompleted
-
Ottawa Hospital Research InstituteUnknownSocial Isolation | Comorbidities and Coexisting Conditions
-
NORCE Norwegian Research Centre ASCompleted